REGENERON PHARMACEUTICALS, INC. (REGN) FY2024 Q3 Balance Sheet

REGENERON PHARMACEUTICALS, INC. (REGN) FY2024 Q3 Balance Sheet

Balance sheet as of 2024-09-30. The chart shows assets, liabilities and equity at that date.

Assets

37,441,900,000 US dollars

Current assets

19,333,600,000 US dollars

Non-current assets

18,108,300,000 US dollars

Liabilities

8,116,000,000 US dollars

Current liabilities

3,661,000,000 US dollars

Non-current liabilities

4,455,000,000 US dollars

Equity

29,325,900,000 US dollars

Marketable securities

7,784,700,000 US dollars

Accounts receivable, net

6,107,100,000 US dollars

Inventories

3,018,000,000 US dollars

Cash and cash equivalents

2,011,800,000 US dollars

Prepaid expenses and other current assets

412,000,000 US dollars

Marketable securities

8,490,900,000 US dollars

Property, plant, and equipment, net

4,439,200,000 US dollars

Deferred tax assets

3,015,100,000 US dollars

Intangible assets, net

1,120,100,000 US dollars

Other noncurrent assets

1,043,000,000 US dollars

Accrued expenses and other current liabilities

2,536,500,000 US dollars

Deferred revenue

627,200,000 US dollars

Accounts payable

497,300,000 US dollars

Long-term debt

1,984,000,000 US dollars

Other noncurrent liabilities

1,543,600,000 US dollars

Finance lease liabilities

720,000,000 US dollars

Deferred revenue

207,400,000 US dollars

Retained earnings

30,755,200,000 US dollars

Additional paid-in capital

12,702,800,000 US dollars

Accumulated other comprehensive income (loss)

60,200,000 US dollars

Common stock - Common Stock

100,000 US dollars

Common stock - Class A Stock

0 US dollars

Preferred Stock, par value $.01 per share; 30.0 shares authorized; shares issued and outstanding - none

0 US dollars

Treasury Stock, at cost; 27.0 shares in 2024 and 25.5 shares in 2023

negative 14,192,400,000 US dollars

Gross equity (calculated)

43,518,300,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.